Detail (Long)
LAIV3 additional precautions:<br>
◦ Influenza antivirals might interfere w/ LAIV3 if initiated ≤2wk after vaccination. Pts who receive antivirals w/in a specified time frame before receipt of LAIV3 (48h for oseltamivir and zanamivir, 5 days for peramivir, and 17 days for baloxavir) through 2wk after receipt of LAIV3 should be revaccinated w/ an age-appropriate IIV3 or RIV3.<br>
◦ Asthma in individuals ≥5 yo<br>
◦ Other underlying medical conditions that might predispose to complications after wild-type influenza infection (e.g., chronic pulmonary, CV [except isolated HTN], renal, hepatic, neurologic, hematologic, or metabolic diseases [including DM])
◦ Influenza antivirals might interfere w/ LAIV3 if initiated ≤2wk after vaccination. Pts who receive antivirals w/in a specified time frame before receipt of LAIV3 (48h for oseltamivir and zanamivir, 5 days for peramivir, and 17 days for baloxavir) through 2wk after receipt of LAIV3 should be revaccinated w/ an age-appropriate IIV3 or RIV3.<br>
◦ Asthma in individuals ≥5 yo<br>
◦ Other underlying medical conditions that might predispose to complications after wild-type influenza infection (e.g., chronic pulmonary, CV [except isolated HTN], renal, hepatic, neurologic, hematologic, or metabolic diseases [including DM])